Your browser doesn't support javascript.
loading
Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma.
Merkx, Robin I J; Lobeek, Daphne; Konijnenberg, Mark; Jiménez-Franco, Luis David; Kluge, Andreas; Oosterwijk, Egbert; Mulders, Peter F A; Rijpkema, Mark.
Afiliação
  • Merkx RIJ; Department of Medical Imaging: Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands. Robin.Merkx@radboudumc.nl.
  • Lobeek D; Department of Urology, Radboudumc, Nijmegen, The Netherlands. Robin.Merkx@radboudumc.nl.
  • Konijnenberg M; Department of Medical Imaging: Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
  • Jiménez-Franco LD; Department of Medical Imaging: Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
  • Kluge A; ABX-CRO advanced pharmaceutical services, Dresden, Germany.
  • Oosterwijk E; ABX-CRO advanced pharmaceutical services, Dresden, Germany.
  • Mulders PFA; Department of Urology, Radboudumc, Nijmegen, The Netherlands.
  • Rijpkema M; Department of Urology, Radboudumc, Nijmegen, The Netherlands.
Eur J Nucl Med Mol Imaging ; 48(10): 3277-3285, 2021 09.
Article em En | MEDLINE | ID: mdl-33651116
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article